Scholarlink

Background <p>Although two-stage revision arthroplasty achieves favorable infection control rates, a substantial proportion of patients experience spacer retention or short-term mortality. Therefore, the goal of this study was to identify preoperative risk factors associated with spacer retention and mortality during a two-stage approach.</p> Methods <p>This single-center retrospective cohort study included a consecutive series of 90 chronic periprosthetic joint infections (PJI) of the hip treated with a two-stage revision between August 2017 and December 2021. Associations between potential risk factors and outcomes were analyzed using correlation analyses,&#xa0;and the effect size was quantified by&#xa0;Spearman's rho (r). Mortality rates were estimated using the Kaplan–Meier method and compared with the log-rank test.</p> Results <p>After a mean follow-up of 48&#xa0;months (range 24 to 73), 19 patients (21%) did not undergo reimplantation, 23 patients (25.5%) had died, and two patients (2%) were lost to follow-up. Successful reimplantation was significantly associated with implantation of an articulating hip spacer (<i>r</i> = 0.57) and favorable periarticular soft tissue conditions (<i>r</i> = 0.25). Mortality was significantly correlated with a higher comorbidity burden (ASA ≥ 3; <i>r</i> = 0.36) and advanced age (≥ 80&#xa0;years; <i>r</i> = 0.22).</p> Conclusion <p>This study identified three simple, yet powerful prognostic markers of spacer retention and mortality. Implantation of an articulating hip spacer emerged as the strongest positive predictor of successful reimplantation, although it likely functions, at least in part, as a surrogate marker for favorable local bone and soft-tissue conditions. In contrast, advanced age and a high comorbidity burden were the strongest predictors of short-term mortality. These readily assessable prognostic markers may facilitate the identification of patients at the highest risk of not&#xa0;completing a two-stage approach or dying shortly after.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Preoperative predictors of spacer retention and mortality in two-stage revision for infected total hip arthroplasties: a single-center experience of 90 patients

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月13日

查看全文
  • Andre Lunz,
  • Jascha Fell,
  • Kevin-Arno Koch,
  • Axel Horsch,
  • Andreas Geisbüsch,
  • Burkhard Lehner

摘要

Background

Although two-stage revision arthroplasty achieves favorable infection control rates, a substantial proportion of patients experience spacer retention or short-term mortality. Therefore, the goal of this study was to identify preoperative risk factors associated with spacer retention and mortality during a two-stage approach.

Methods

This single-center retrospective cohort study included a consecutive series of 90 chronic periprosthetic joint infections (PJI) of the hip treated with a two-stage revision between August 2017 and December 2021. Associations between potential risk factors and outcomes were analyzed using correlation analyses, and the effect size was quantified by Spearman's rho (r). Mortality rates were estimated using the Kaplan–Meier method and compared with the log-rank test.

Results

After a mean follow-up of 48 months (range 24 to 73), 19 patients (21%) did not undergo reimplantation, 23 patients (25.5%) had died, and two patients (2%) were lost to follow-up. Successful reimplantation was significantly associated with implantation of an articulating hip spacer (r = 0.57) and favorable periarticular soft tissue conditions (r = 0.25). Mortality was significantly correlated with a higher comorbidity burden (ASA ≥ 3; r = 0.36) and advanced age (≥ 80 years; r = 0.22).

Conclusion

This study identified three simple, yet powerful prognostic markers of spacer retention and mortality. Implantation of an articulating hip spacer emerged as the strongest positive predictor of successful reimplantation, although it likely functions, at least in part, as a surrogate marker for favorable local bone and soft-tissue conditions. In contrast, advanced age and a high comorbidity burden were the strongest predictors of short-term mortality. These readily assessable prognostic markers may facilitate the identification of patients at the highest risk of not completing a two-stage approach or dying shortly after.